Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 31;19(1):458.
doi: 10.1186/s12936-020-03561-6.

Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces

Bui Van Long  1 , Genevieve Allen  1 , Melanie Brauny  1 , Le Thi Kieu Linh  1   2 , Srinivas Reddy Pallerla  1 , Tran Thi Thu Huyen  3 , Hoang Van Tong  3   4 , Nguyen Linh Toan  3 , Do Quyet  5 , Ho Anh Son  6 , Thirumalaisamy P Velavan  7   8
Affiliations

Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces

Bui Van Long et al. Malar J. .

Abstract

Background: While the World Health Organization (WHO) Southeast Asia region has the second highest incidence of malaria worldwide, malaria in Vietnam is focal to few provinces, where delayed parasite clearance to anti-malarial drugs is documented. This study aims to understand Plasmodium species distribution and the genetic diversity of msp1 and msp2 of parasite populations using molecular tools.

Methods: A total of 222 clinical isolates from individuals with uncomplicated malaria were subjected to Plasmodium species identification by nested real-time PCR. 166 isolates positive for Plasmodium falciparum mono infections were further genotyped for msp1 (MAD20, K1, and RO33), and msp2 allelic families (3D7 and FC27). Amplicons were resolved through capillary electrophoresis in the QIAxcel Advanced system.

Results: Mono-infections were high and with 75% P. falciparum, 14% Plasmodium vivax and 9% P. falciparum/P. vivax co-infections, with less than 1% Plasmodium malariae identified. For msp1, MAD20 was the most prevalent (99%), followed by K1 (46%) allelic family, with no sample testing positive for RO33 (0%). For msp2, 3D7 allelic family was predominant (97%), followed by FC27 (10%). The multiplicity of infection of msp1 and msp2 was 2.6 and 1.1, respectively, and the mean overall multiplicity of infection was 3.7, with the total number of alleles ranging from 1 to 7.

Conclusions: Given the increasing importance of antimalarial drugs in the region, the genetic diversity of P. falciparum msp1 and msp2 should be regularly monitored with respect to treatment outcomes and/or efficacy studies in regions, where there are ongoing changes in the malaria epidemiology.

Keywords: Malaria; Multiplicity of infection; Species; Vietnam; msp1; msp2.

PubMed Disclaimer

Conflict of interest statement

All authors disclose no competing interests.

Figures

Fig. 1
Fig. 1
High-resolution capillary electrophoresis in a QIAxcel Advanced system, Amplicons were separated based on size and were subsequently analysed with QIAxcel ScreenGel software
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO . World malaria report 2019. Geneva: World Health Organization; 2019.
    1. Goldlust SM, Thuan PD, Giang DDH, Thang ND, Thwaites GE, Farrar J, et al. The decline of malaria in Vietnam, 1991–2014. Malar J. 2018;17:226. doi: 10.1186/s12936-018-2372-8. - DOI - PMC - PubMed
    1. Phuong NL. Viet Nam ready to eliminate malaria. Geneva: World Health Organization; 2018.
    1. Velavan TP, Nderu D, Agbenyega T, Ntoumi F, Kremsner PG. An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west. Proc Natl Acad Sci USA. 2019;116:12611–2. doi: 10.1073/pnas.1907142116. - DOI - PMC - PubMed
    1. Kremsner PG, Adegnika AA, Hounkpatin AB, Zinsou JF, Taylor TE, Chimalizeni Y, et al. Intramuscular artesunate for severe malaria in African children: a multicenter randomized controlled trial. PLoS Med. 2016;13:e1001938. doi: 10.1371/journal.pmed.1001938. - DOI - PMC - PubMed

MeSH terms

Substances